用MRI光谱定义胶质母细胞瘤的隐匿性疾病:对临床靶体积描绘的意义。

IF 3.3 2区 医学 Q2 ONCOLOGY
Jonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, Kaylie Cullison, Gregory A Azzam, Jessica Meshman, Matthew C Abramowitz, Michael E Ivan, Macarena I de la Fuente, Eric A Mellon
{"title":"用MRI光谱定义胶质母细胞瘤的隐匿性疾病:对临床靶体积描绘的意义。","authors":"Jonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, Kaylie Cullison, Gregory A Azzam, Jessica Meshman, Matthew C Abramowitz, Michael E Ivan, Macarena I de la Fuente, Eric A Mellon","doi":"10.1186/s13014-025-02666-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Outcomes in glioblastoma are improved by surgical resection and adjuvant radiation (RT). In primary GBM (pGBM), large clinical target volume (CTV) margins typically cover occult invasion. In recurrent GBM (rGBM), RT often uses tiny CTV margins that likely omit occult invasion due to re-RT radiation necrosis concerns. Whole-brain spectroscopic MRI (sMRI) is an emerging technique with similar resolution to PET that may help define the CTV for rGBM.</p><p><strong>Methods: </strong>Patients with pGBM (n = 18) and rGBM (n = 19) underwent sMRI with RT simulation. T1-post contrast (T1PC) and T2/FLAIR MRI volumes were contoured. sMRI generated choline/N-acetylaspartate > 2x (Cho/NAA > 2x) volumes are known to correlate with high-risk invasion. Hausdorff distances were calculated to define the margin necessary to cover Cho/NAA > 2x in pGBM and rGBM. In rGBM, mock CTV expansions from T1PC volumes were created to determine non-selective CTV expansion sizes needed to cover Cho/NAA > 2x volumes.</p><p><strong>Results: </strong>For pGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 32.3 cc, 45.0 cc, and 74.8 cc respectively. For rGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 21.7 cc, 58.9 cc, and 118.3 cc, respectively. T2/FLAIR volumes increased more relative to T1PC volumes in rGBM than pGBM (p ≤ 0.001). Meanwhile, the median Hausdorff distance between T1PC and Cho/NAA > 2x was 22.9 mm in pGBM and 25.7 mm in rGBM, suggesting that the high-risk volume does not significantly change. In rGBM, it is common to use no CTV expansion from the T1PC volume which only included 61% of high-risk Cho/NAA > 2x volume. Conversely, T1PC expansions of 10-, 15-, and 20-mm covered 87%, 94%, and 98% of Cho/NAA > 2x volume.</p><p><strong>Conclusions: </strong>sMRI Cho/NAA > 2x delineates high-risk occult disease in glioblastoma and extends beyond T1PC MRI borders. Typical large CTV expansions in pGBM mostly include Cho/NAA > 2x volumes. However, small CTV expansions commonly used in rGBM poorly cover Cho/NAA > 2x, suggesting that larger CTV expansions or Cho/NAA > 2x guidance may be of benefit.</p>","PeriodicalId":49639,"journal":{"name":"Radiation Oncology","volume":"20 1","pages":"86"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100854/pdf/","citationCount":"0","resultStr":"{\"title\":\"Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.\",\"authors\":\"Jonathan B Bell, Sulaiman Sheriff, Mohammed Z Goryawala, Kaylie Cullison, Gregory A Azzam, Jessica Meshman, Matthew C Abramowitz, Michael E Ivan, Macarena I de la Fuente, Eric A Mellon\",\"doi\":\"10.1186/s13014-025-02666-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Outcomes in glioblastoma are improved by surgical resection and adjuvant radiation (RT). In primary GBM (pGBM), large clinical target volume (CTV) margins typically cover occult invasion. In recurrent GBM (rGBM), RT often uses tiny CTV margins that likely omit occult invasion due to re-RT radiation necrosis concerns. Whole-brain spectroscopic MRI (sMRI) is an emerging technique with similar resolution to PET that may help define the CTV for rGBM.</p><p><strong>Methods: </strong>Patients with pGBM (n = 18) and rGBM (n = 19) underwent sMRI with RT simulation. T1-post contrast (T1PC) and T2/FLAIR MRI volumes were contoured. sMRI generated choline/N-acetylaspartate > 2x (Cho/NAA > 2x) volumes are known to correlate with high-risk invasion. Hausdorff distances were calculated to define the margin necessary to cover Cho/NAA > 2x in pGBM and rGBM. In rGBM, mock CTV expansions from T1PC volumes were created to determine non-selective CTV expansion sizes needed to cover Cho/NAA > 2x volumes.</p><p><strong>Results: </strong>For pGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 32.3 cc, 45.0 cc, and 74.8 cc respectively. For rGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 21.7 cc, 58.9 cc, and 118.3 cc, respectively. T2/FLAIR volumes increased more relative to T1PC volumes in rGBM than pGBM (p ≤ 0.001). Meanwhile, the median Hausdorff distance between T1PC and Cho/NAA > 2x was 22.9 mm in pGBM and 25.7 mm in rGBM, suggesting that the high-risk volume does not significantly change. In rGBM, it is common to use no CTV expansion from the T1PC volume which only included 61% of high-risk Cho/NAA > 2x volume. Conversely, T1PC expansions of 10-, 15-, and 20-mm covered 87%, 94%, and 98% of Cho/NAA > 2x volume.</p><p><strong>Conclusions: </strong>sMRI Cho/NAA > 2x delineates high-risk occult disease in glioblastoma and extends beyond T1PC MRI borders. Typical large CTV expansions in pGBM mostly include Cho/NAA > 2x volumes. However, small CTV expansions commonly used in rGBM poorly cover Cho/NAA > 2x, suggesting that larger CTV expansions or Cho/NAA > 2x guidance may be of benefit.</p>\",\"PeriodicalId\":49639,\"journal\":{\"name\":\"Radiation Oncology\",\"volume\":\"20 1\",\"pages\":\"86\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-05-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100854/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiation Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13014-025-02666-z\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13014-025-02666-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:手术切除和辅助放疗(RT)可以改善胶质母细胞瘤的预后。在原发性GBM (pGBM)中,较大的临床靶体积(CTV)边缘通常覆盖隐匿性侵犯。在复发性GBM (rGBM)中,RT通常使用微小的CTV边缘,可能忽略由于再RT辐射坏死的隐蔽性侵犯。全脑磁共振成像(sMRI)是一种与PET分辨率相似的新兴技术,可以帮助确定rGBM的CTV。方法:pGBM (n = 18)和rGBM (n = 19)患者行sMRI伴RT模拟。t1 -对比后(T1PC)和T2/FLAIR MRI体积轮廓。sMRI产生的胆碱/ n -乙酰天冬氨酸> 2x (Cho/NAA > 2x)体积已知与高危侵袭相关。计算Hausdorff距离,以定义在pGBM和rGBM中覆盖Cho/NAA b> 2x所需的余量。在rGBM中,创建来自T1PC卷的模拟CTV扩展,以确定覆盖Cho/NAA > 2x卷所需的非选择性CTV扩展尺寸。结果:对于pGBM,中位T1PC, Cho/NAA > 2x和T2/FLAIR体积分别为32.3 cc, 45.0 cc和74.8 cc。对于rGBM, T1PC、Cho/NAA的中位容积分别为21.7 cc、58.9 cc和118.3 cc。相对于T1PC体积,rGBM患者T2/FLAIR体积比pGBM患者增加更多(p≤0.001)。同时,T1PC与Cho/NAA > 2x之间的Hausdorff距离中位数pGBM为22.9 mm, rGBM为25.7 mm,提示高危容积无明显变化。在rGBM中,通常不使用T1PC体积的CTV扩展,仅包括61%的高风险Cho/NAA > 2x体积。相反,10-、15-和20-mm的T1PC膨胀覆盖了Cho/NAA > 2x体积的87%、94%和98%。结论:sMRI Cho/NAA > 2x描绘了胶质母细胞瘤的高风险隐匿性疾病,并扩展到T1PC MRI边界之外。pGBM中典型的大型CTV扩展主要包括Cho/NAA bb102x体积。然而,通常用于rGBM的小CTV扩展很难覆盖Cho/NAA > 2x,这表明更大的CTV扩展或Cho/NAA > 2x指导可能是有益的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.

Defining occult disease in glioblastoma using spectroscopic MRI: implications for clinical target volume delineation.

Background: Outcomes in glioblastoma are improved by surgical resection and adjuvant radiation (RT). In primary GBM (pGBM), large clinical target volume (CTV) margins typically cover occult invasion. In recurrent GBM (rGBM), RT often uses tiny CTV margins that likely omit occult invasion due to re-RT radiation necrosis concerns. Whole-brain spectroscopic MRI (sMRI) is an emerging technique with similar resolution to PET that may help define the CTV for rGBM.

Methods: Patients with pGBM (n = 18) and rGBM (n = 19) underwent sMRI with RT simulation. T1-post contrast (T1PC) and T2/FLAIR MRI volumes were contoured. sMRI generated choline/N-acetylaspartate > 2x (Cho/NAA > 2x) volumes are known to correlate with high-risk invasion. Hausdorff distances were calculated to define the margin necessary to cover Cho/NAA > 2x in pGBM and rGBM. In rGBM, mock CTV expansions from T1PC volumes were created to determine non-selective CTV expansion sizes needed to cover Cho/NAA > 2x volumes.

Results: For pGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 32.3 cc, 45.0 cc, and 74.8 cc respectively. For rGBM, the median T1PC, Cho/NAA > 2x, and T2/FLAIR volumes were 21.7 cc, 58.9 cc, and 118.3 cc, respectively. T2/FLAIR volumes increased more relative to T1PC volumes in rGBM than pGBM (p ≤ 0.001). Meanwhile, the median Hausdorff distance between T1PC and Cho/NAA > 2x was 22.9 mm in pGBM and 25.7 mm in rGBM, suggesting that the high-risk volume does not significantly change. In rGBM, it is common to use no CTV expansion from the T1PC volume which only included 61% of high-risk Cho/NAA > 2x volume. Conversely, T1PC expansions of 10-, 15-, and 20-mm covered 87%, 94%, and 98% of Cho/NAA > 2x volume.

Conclusions: sMRI Cho/NAA > 2x delineates high-risk occult disease in glioblastoma and extends beyond T1PC MRI borders. Typical large CTV expansions in pGBM mostly include Cho/NAA > 2x volumes. However, small CTV expansions commonly used in rGBM poorly cover Cho/NAA > 2x, suggesting that larger CTV expansions or Cho/NAA > 2x guidance may be of benefit.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Radiation Oncology
Radiation Oncology ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
6.50
自引率
2.80%
发文量
181
审稿时长
3-6 weeks
期刊介绍: Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信